Approvals/NMPA/Recombinant Human Tumor Necrosis Factor-α ReceptorⅡ:IgG Fc Fusion Protein for Injection

Approved

生物制品

Recombinant Human Tumor Necrosis Factor-α ReceptorⅡ:IgG Fc Fusion Protein for Injection

杭州博之锐生物制药有限公司🇨🇳 National Medical Products Administration

Approval Id: 7LeafctToAi
Approval Number: 国药准字S20150005
Generic Name: 注射用重组人Ⅱ型肿瘤坏死因子受体-抗体融合蛋白
Generic Name En: Recombinant Human Tumor Necrosis Factor-α ReceptorⅡ:IgG Fc Fusion Protein for Injection
Drug Type: 生物制品
Dosage Form: 注射剂
Strength: 12.5mg/瓶,生物学活性为1.25×10^6AU/瓶
Reg Date: 2024-09-03
Company Name: 杭州博之锐生物制药有限公司
Company Address: 浙江省杭州市富阳区胥口镇海正路8号
Production Company Name: 杭州博之锐生物制药有限公司
Production Company Address: 浙江省杭州市富阳区胥口镇海正路8号
Company Detail Path: /organization/hang-zhou-bo-zhi-rui-sheng-wu-zhi-yao-you-xian-gong-si
Production Company Detail Path: /organization/hang-zhou-bo-zhi-rui-sheng-wu-zhi-yao-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 3, 2024

Approval ID

7LeafctToAi

Type

生物制品